Cortegoso Aurita Veronica Beovide, Laureano Natalia Koerich, Silva Alessandra Dutra da, Danilevicz Chris Krebs, Magnusson Alessandra Sellinger, Visioli Fernanda, Rados Pantelis Varvaki
Universidad de la República del Uruguay, Facultad de Odontología, Montevideo, Uruguay.
Universidade Federal do Rio Grande do Sul, Faculdade de Odontologia, Departamento de Patologia Oral, Porto Alegre, RS, Brasil.
J Appl Oral Sci. 2017 May-Jun;25(3):318-323. doi: 10.1590/1678-7757-2016-0238.
To evaluate the number of AgNORs per nucleus and the expression of Ki-67 at the tumor invasion front (TIF) in relation to clinical parameters (TNM), TIF classification and the prognosis of oral squamous cell carcinomas in an Uruguayan population.
This study was conducted through a retrospective survey from 2000 to 2010 at the National Institute of Cancer Montevideo, Uruguay and included 40 patients. The samples were obtained from the resection of the tumor and the TIF was defined according with Bryne, et al.5 (1992). Expression of Ki-67 was assessed by the percentage of positive tumor cells and the AgNOR was recorded as the mean AgNOR (mAgNOR) and the percentage of AgNOR per nucleus (pAgNOR). All analyzes were performed by a blinded and calibrated observer.
No statistically significant association was observed between immunostaining of Ki-67 and AgNOR with the different types of TIF, regional metastasis and patients prognosis, however it was observed an increase in Ki-67 expression associated with worse patient's clinical staging, although not statistically significant.
Our results suggest that proliferation markers as AgNOR and Ki-67 are not prognostic markers at the tumor invasive front of carcinoma of oral squamous cell.
评估乌拉圭人群中口腔鳞状细胞癌患者肿瘤浸润前沿(TIF)处每个细胞核的银染核仁组织区(AgNOR)数量及Ki-67的表达情况,并分析其与临床参数(TNM)、TIF分类及预后的关系。
本研究通过对乌拉圭蒙得维的亚国家癌症研究所2000年至2010年期间的40例患者进行回顾性调查开展。样本取自肿瘤切除术,TIF根据Bryne等人(1992年)的标准定义。通过阳性肿瘤细胞百分比评估Ki-67的表达,AgNOR记录为平均AgNOR(mAgNOR)和每个细胞核的AgNOR百分比(pAgNOR)。所有分析均由一名经过盲法校准的观察者进行。
未观察到Ki-67免疫染色和AgNOR与不同类型的TIF、区域转移及患者预后之间存在统计学显著关联,不过观察到Ki-67表达增加与患者临床分期较差相关,尽管无统计学显著性。
我们的结果表明,在口腔鳞状细胞癌的肿瘤浸润前沿,AgNOR和Ki-67等增殖标志物并非预后标志物。